Achilles Therapeutics News

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(1.9%),Invus Public Equities Advisors, LLC(1.9%), etc.

Mar 29 16:33 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(8.1%),Baker Bros. Advisors (GP) LLC(8.1%), etc.

Feb 14 17:49 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 13 18:46 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(3.9%),Jeremy C. Green(3.9%)

Feb 14, 2023 16:29 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.9%),Baker Bros. Advisors (GP) LLC(9.9%), etc.

Feb 14, 2023 16:00 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.

Feb 14, 2023 16:00 ET

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(5.5%),Invus Public Equities Advisors, LLC(5.5%), etc.

Feb 10, 2023 19:15 ET

Achilles Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(3.93%),Peter Kolchinsky(3.93%), etc.

Dec 30, 2022 16:57 ET

Achilles Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(7.27%),Peter Kolchinsky(7.27%), etc.

Dec 23, 2022 17:15 ET

Achilles Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.03%),Peter Kolchinsky(10.03%), etc.

Dec 15, 2022 17:01 ET

Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(5.3%),Point72 Capital Advisors, Inc.(5.3%), etc.

Jul 25, 2022 17:20 ET

Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Redmile Group, LLC(5.1%),Jeremy C. Green(5.1%)

Feb 14, 2022 17:07 ET

Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%), etc.

Feb 14, 2022 16:12 ET

Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

Feb 11, 2022 12:22 ET

Achilles Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forbion Capital Fund IV Coöperatief U.A.(5.89%),Forbion IV Management B.V.(5.89%)

Feb 11, 2022 09:20 ET

Achilles Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Apr 16, 2021 16:34 ET

Achilles Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Apr 15, 2021 17:02 ET